Frontlight ResearchEarly access
Taking people in FranceNo phase
Collects data from people with prostate cancer at one cancer institute
Records information from adults with prostate cancer treated at one cancer institute.
Key facts
- Who runs it
- Institut Paoli-Calmettes
- Where
- Marseille, FranceSee the site
- Trial code
- Registry title
- Institut Paoli Calmettes Prostate Cancer Database
- Status
- Recruiting
- People taking part
- 10,000 people, planned
- Started
- Jan 2010
- Expected to end
- Dec 2030
- Type of study
- Observational
- Treatments tested
- Data collection
- Record updated
- 17 August 2016
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for men with prostate cancer. It collects data on patients of the Institut Paoli-Calmettes.
- Age
- 18 Years to 95 Years
- Sex
- Men only
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Prostatic cancer
Who cannot take part
- Non applicable
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 95 years old?
Where in France
- Institut Paoli-CalmettesMarseille, FranceContact: Dominique GENRE, MDTaking people
About the trial
What the trial wants to find out
Database of Institut Paoli-Calmettes patients diagnosed with prostate cancer
The group in the trial
- Patients with prostate cancer diagnosis
Treatment: Data collection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Institut Paoli Calmettes Prostate Cancer Database
- Plain-language title
- Collects data from people with prostate cancer at one cancer instituteGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT02869594, who can take part
- Record updated
- 17 August 2016